First U.S. Procedure with Cartiva Synthetic Cartilage Implant

The first commercial U.S. patient has received the Cartiva Synthetic Cartilage Implant (SCI) following its FDA Premarket Approval. SCI is intended for use in the treatment of great toe arthritis.

SCI presents an alternative to fusion, the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us